Carmantadine
Carmantadine is an antiparkinsonian agent of the adamantane group that was never marketed. It is structurally related to amantadine and shares some of its pharmacological actions. Another related drug is dopamantine. Carmantadine was first described by 1972 and is said to have reached early clinical trials.